AMA statement on FDA approval of implant to fight opioid addiction

| 1 Min Read

"The AMA is pleased the FDA approved a new implantable option to help treat patients with substance use disorders. With nearly 2 million Americans needing treatment for opioid use disorder, patients will benefit from increased options for medication-assisted treatment.

 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Columns of the U.S. Supreme Court at top of steps

8 wins for doctors, patients in latest federal budget deal

| 4 Min Read
Wooden blocks and figures accompany an up arrow

Do physicians need to switch jobs to climb the career ladder?

| 5 Min Read
Physician walking down a hallway

Women physicians face heavier burdens and higher burnout risk

| 9 Min Read
Adhesive bandage applied to upper arm of smiling young patient

Pediatric vaccines: Questions parents will ask—and how to answer

| 8 Min Read